The U.K. is poised to become the first country to approvePfizer Inc. andBioNTech SE’s Covid-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus.
Clearance is possible as soon as early next week, according to a person familiar with the situation, who asked not to be identified because the process is confidential.
The U.K. had long signaled it would move fast on any promising vaccine candidate. Russia and China have cleared vaccines for general use, but they’re unlikely to be adopted in the U.S. and Europe.
British doctors were put onstandby for a possible rollout before Christmas. The government invoked a special rule allowing the U.K. drug regulator to bypass its European Union counterpart as the country prepares for the Brexit transition period to conclude at the end of this year. And the U.K.’s Medicines and Healthcare Products Regulatory Agency started its own accelerated review.
205,557 in U.S.Most new cases today
+8% Change in MSCI World Index of global stocks since Wuhan lockdown, Jan. 23
-0.8952 Change in U.S. treasury bond yield since Wuhan lockdown, Jan. 23
4% Global GDP Tracker (annualized), Oct.